This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

Slides:



Advertisements
Similar presentations
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Thrombectomy for Acute Ischemic Stroke:
Advertisements

Thrombectomy in Acute Stroke
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
Evolving Standards in HER2-Targeted Adjuvant Therapy for Breast Cancer
Immunotherapies: Key Considerations in the Identification and Management of irAEs.
Evolving Paradigms in the Management of HR-Positive Breast Cancer
Current Management and Future Options for Tardive Dyskinesia
New Psoriasis Treatments
Applying Biosimilars in Hematologic Cancers
Improving Survival in Glioblastoma Multiforme
Case Studies.
Progression After Cancer Immunotherapy in Advanced NSCLC
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
New Standards of Care in ALK-Translocated Advanced NSCLC
Atopic Dermatitis Treatment Landscape
Mid-Year Hemophilia Update
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.
PARP Inhibitors and Cancer: What Do You Need to Know?
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Navigating the Data and Evolving Our Approach
Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma
Addressing Disease Burden in Asthma
The Evolving Role of Immunotherapy in NSCLC
Optimizing Management of Advanced Bladder Cancer
Updates in Preventing Skeletal-Related Events in Multiple Myeloma
Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Next-Gen Psoriasis Therapies:
Evaluating Next-Generation BTK Inhibitors
Case Studies in Unresectable Hepatocellular Carcinoma
Hyperhidrosis Is Burdensome!
Therapeutic Approaches to the Management of EDS in OSA
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Immunotherapy for cSCC
CGRP Antibodies in Migraine
Optimizing Frontline Care for Older Patients With Multiple Myeloma
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
How to Select Therapy In Newly Diagnosed CLL
Advancing Care Across the Spectrum of Pancreatic Cancer
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Parkinson Disease Psychosis
Talking With Your Patients About Excessive Sweating
Getting to Grips With the Science of CGRP and Migraine
Advances in Immunotherapy for Peanut Allergy
Guide to Atopic Dermatitis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Managing Your Patient’s Maintenance Therapy for Multiple Myeloma
Patient Questions and Expert Answers in Psoriasis:
The Role of Maintenance Therapy in Multiple Myeloma
All for One: Multidisciplinary Management in EGFR-Mutated NSCLC
The Psychiatrist's Role in Tardive Dyskinesia
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Novel Concepts in the Management of RCC
Figure 3 Multivariate regression analysis to display the impact of recanalization on the formation of ischaemic brain ... Figure 3 Multivariate regression.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
From Adjuvant to Metastatic in Melanoma
Why New Treatments for Hyperhidrosis Should Be on Your Radar
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
The Psychiatrist's Role in Tardive Dyskinesia
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
Checkpoint Inhibitors in First-Line Advanced NSCLC
VKA Reversal and LVADs.
CDK4/6 Inhibitors.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Immune Checkpoint Inhibitors in Lung Cancer
Presentation transcript:

Tools for Patient Selection for Mechanical Clot Retrieval in Ischemic Stroke

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

Program Goals

Device Trials

Blood Supply of the Brain

Modified Thrombolysis in Cerebral Infarction (mTICI) Score

Time is Brain

Guidelines

Modified Rankin Score

Blood Supply of the Brain

National Institutes of Health Stroke Scale: NIHSS

Alberta Stroke Program Early CT Score: ASPECTS

HERMES

ESCAPE Trial

Ongoing Trials

Every Minute Matters

The Role of the Neurologist

Time is Brain

Large Vessel Occlusions

Identifying LVOs - Scales

Stroke Centers

Future Directions for Thrombectomy

Registries

Summary

Importance of Team Work

Abbreviations